In a world where technology and health are becoming increasingly intertwined, digital biomarkers quickly emerge as game-changers in monitoring, diagnosing, and treating disease. These tech-enabled indicators—captured from everyday digital devices—are not only empowering patients but also helping healthcare professionals gain unprecedented real-time insights into individual health.
Digital biomarkers are objective, measurable physiological and behavioral data collected via digital devices such as smartphones, wearable sensors, smartwatches, and health apps. Unlike traditional biomarkers—like blood pressure readings or lab test results—digital biomarkers are gathered passively and continuously, offering a dynamic view of a person’s health in their natural environment.
For example, subtle changes in voice patterns or typing speed on a smartphone could help detect early signs of neurological diseases like Parkinson’s. Heart rate variability recorded from a smartwatch can reveal stress levels, sleep quality, or cardiovascular risk.
The global digital biomarker market is estimated to expand from $5 billion in 2025 to $18.8 billion by the end of 2030, registering a robust 30.4% CAGR. Several key factors are fueling this surge: